BioTech / Drug Discovery Funding

Sector profile · 1 tracked rounds · $50 million tracked capital

Capvizr tracks BioTech / Drug Discovery funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company XellarLargest round $50 million1 deals

Recent BioTech / Drug Discovery rounds

Xellar · $50 million · Series A · July 1, 2026

Market context

BioTech / Drug Discovery deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open BioTech / Drug Discovery in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime